Cytidinediphosphocholine treatment to decrease traumatic brain injury-induced hippocampal neuronal death, cortical contusion volume, and neurological dysfunction in rats

J Neurosurg. 2003 Apr;98(4):867-73. doi: 10.3171/jns.2003.98.4.0867.

Abstract

Object: In previous studies at their laboratory the authors showed that cytidinediphosphocholine (CDP-choline), an intermediate of phosphatidylcholine synthesis, decreases edema formation and blood-brain barrier disruption following traumatic brain injury (TBI). In the present study the authors investigate whether CDP-choline protects hippocampal neurons after controlled cortical impact (CCI)-induced TBI in adult rats.

Methods: After adult male Sprague-Dawley rats had been anesthetized with halothane, a moderate-grade TBI was induced with the aid of a CCI device set at a velocity of 3 m/second, creating a 2-mm deformation. Sham-operated rats, which underwent craniectomy without impact served as controls. The CDP-choline (100, 200, and 400 mg/kg body weight) or saline was injected into the animals twice (once immediately postinjury and once 6 hours postinjury). Seven days after the injury, the rats were neurologically evaluated and killed, and the number of hippocampal neurons was estimated by examining thionine-stained brain sections. By 7 days postinjury, there was a significant amount of neuronal death in the ipsilateral hippocampus in the CA2 (by 53 +/- 7%, p < 0.05) and CA3 (by 59 +/- 9%, p < 0.05) regions and a contusion (volume 34 +/- 8 mm3) in the ipsilateral cortex compared with sham-operated control animals. Rats subjected to TBI also displayed severe neurological deficit at 7 days postinjury. Treating rats with CDP-choline (200 and 400 mg/kg, intraperitoneally) significantly prevented TBI-induced neuronal loss in the hippocampus, decreased cortical contusion volume, and improved neurological recovery.

Conclusions: Treatment with CDP-choline decreased brain damage following TBI.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Brain Injuries* / drug therapy
  • Brain Injuries* / pathology
  • Brain Injuries* / physiopathology
  • Cell Death
  • Cytidine Diphosphate Choline / pharmacology
  • Cytidine Diphosphate Choline / therapeutic use*
  • Disease Models, Animal
  • Hippocampus / pathology*
  • Hippocampus / physiopathology*
  • Male
  • Neurons / pathology
  • Nootropic Agents / pharmacology
  • Nootropic Agents / therapeutic use*
  • Phospholipases / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, N-Methyl-D-Aspartate / drug effects

Substances

  • Nootropic Agents
  • Receptors, N-Methyl-D-Aspartate
  • Cytidine Diphosphate Choline
  • Phospholipases